Mark Stejbach insider trades: Indivior Pharmaceuticals (INDV) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | INDV | ↑ Buy | 775 | $35.39 | $27K | Direct | Jan 7, 2026 (2d) |
| May 26, 2020 | FLXN | ↑ Buy | 2,051 | $9.75 | $20K | Direct | May 27, 2020 (1d) |
| Feb 16, 2018 | ALKS | ↓ Sell | 10,880 | $70.50 | $767K | Direct | Feb 21, 2018 (5d) |
| Jun 16, 2017 | FLXN | ↑ Buy | 1,580 | $17.02 | $27K | By The Mark P. Stejbach Revocable Trust | Jun 20, 2017 (4d) |
| Jun 8, 2017 | ALKS | ↓ Sell | 10,000 | $60.34 | $603K | Direct | Jun 8, 2017 (0d) |
| Jan 9, 2017 | ALKS | ↓ Sell | 547 | $60.27 | $33K | Direct | Jan 10, 2017 (1d) |
| Jan 6, 2017 | ALKS | ↓ Sell | 9,453 | $60.05 | $568K | Direct | Jan 6, 2017 (0d) |
| Dec 28, 2015 | ALKS | ↓ Sell | 10,000 | $80.24 | $802K | Direct | Dec 28, 2015 (0d) |
| Dec 1, 2015 | ALKS | ↓ Sell | 18,000 | $72.18 | $1.3M | Direct | Dec 2, 2015 (1d) |
| Nov 2, 2015 | ALKS | ↓ Sell | 18,000 | $72.06 | $1.3M | Direct | Nov 4, 2015 (2d) |
| Nov 13, 2012 | ALKS | ↑ Buy | 1,200 | $20.13 | $24K | Direct | Nov 19, 2012 (6d) |
| Apr 9, 2010 | TNGN | ↑ Buy | 100 | $5.00 | $500 | Direct | Apr 13, 2010 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other INDV insiders
Open-market trades in the last 12 months
About Mark Stejbach's insider trades
Mark Stejbach is a director at Indivior Pharmaceuticals (INDV). Since Apr 9, 2010, Mark has reported 5 open-market purchases worth $99K and 7 sales worth $5.4M on SEC Form 4. In the last 12 months: 1 buy ($27K).
Their filings also include option exercises (24 filings), grants and awards (18 filings), shares withheld for taxes (13 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INDV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.